VivoSim Labs VIVS
NASDAQ VIVS
$0.28 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Gross Margin (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Gross Margin of 100.0% for Q1 2026, little changed year-over-year from 100.0% in Q1 2025, and little changed quarter-over-quarter from 100.0% in Q4 2025.

VivoSim Labs (VIVS) Gross Margin (2011 - 2026) Analysis & Trends

VivoSim Labs' Gross Margin history runs 10 years deep, the most recent figure standing at 100.0% for Q1 2026.

  • In Q1 2026, Gross Margin changed 0.0% year-over-year to 100.0%; the TTM figure through Mar 2026 stood at 100.0% (up 347.0% YoY), while the FY2026 annual figure was 100.0%, up 347.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 100.0%, roughly flat from 100.0% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q2 2023, with the low at 91.67% in Q4 2024.
  • The 4-year median for Gross Margin is 100.0% (2023), against an average of 98.47%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin slumped 833 bps in 2024, then jumped 833 bps in 2025.
  • VivoSim Labs' Gross Margin stood at 100.0% in 2023, then declined by 8 bps to 91.67% in 2024, then climbed by 9 bps to 100.0% in 2025, then changed by 0 bps to 100.0% in 2026.
  • Business Quant data shows VIVS's Gross Margin at 100.0% in Q1 2026, 100.0% in Q4 2025, and 100.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 91.59%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 90.43%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 35.86%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 89.76%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 76.90%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 84.20%
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 63.27%
10 VivoSim Labs 1.46 Mn 1.46 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 100.00%
Dec 31, 2025 100.00%
Sep 30, 2025 100.00%
Jun 30, 2025 100.00%
Mar 31, 2025 100.00%
Dec 31, 2024 91.67%
Sep 30, 2024 96.67%
Jun 30, 2024 94.87%
Mar 31, 2024 100.00%
Dec 31, 2023 100.00%
Jun 30, 2023 100.00%
Dec 31, 2019 95.64%
Sep 30, 2019 78.54%
Jun 30, 2019 92.37%
Mar 31, 2019 85.15%
Dec 31, 2018 82.54%
Sep 30, 2018 86.74%
Jun 30, 2018 82.58%
Mar 31, 2018 74.39%
Dec 31, 2017 83.35%